LUMO Labs is backing Dutch health-tech startup Autoscriber, which makes a speciality of synthetic intelligence (AI)-supported voice recognition software program that may interpret healthcare session between medical doctors and sufferers, based on a Tuesday (Sept. 7) press launch.
“The issue Autoscriber is fixing is common: decreasing money and time spent on repetitive, administrative duties by physicians whereas growing transparency, comprehensibility and human interplay in deeply private therapy conditions,” LUMO Labs Founding Companion Andy Lürling mentioned within the launch.
He added that Autoscriber’s answer “is dynamic and extremely scalable.”
See additionally: Digital Transformation in Healthcare Funds
The funding for Autoscriber is being offered by LUMO Labs funding arm LUMO Fund II TTT AI. The corporate is backing Autoscriber as a result of the idea can “dramatically enhance the lives of caregivers and sufferers,” based on the discharge.
Learn additionally: 76% of Sufferers Need Digital Healthcare
The subscription-based Software program-as-a-Service (SaaS) providing by Autoscriber is meant to assist well being professionals at hospitals and practices of all sizes, in addition to normal practitioners. Autoscriber “data, transcribes and extracts medical ideas throughout consultations” and allows computerized integration into sufferers’ digital well being data, the discharge said.
Autoscriber Co-Founder and CEO Jacqueline Kazmaier mentioned within the launch that LUMO Labs is the “excellent associate” as it really works towards Autoscriber’s firm mission of “enabling the way forward for healthcare.”
See extra: Healthcare Suppliers Flip to AI to Rein in Fraudsters’ 240-Hour Head Begin
The pre-seed funding from LUMO Labs will allow Autoscriber to go stay in hospitals in lower than a 12 months, based on the discharge. The funding quantity was not disclosed.
The know-how was created in partnership with the Scientific Synthetic Intelligence and Analysis Lab (CAIRELab) at Leiden College Medical Heart.